血液透析

1.Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目观察液透析滤过(HDF)及液透析(HD)对尿毒症脑病疗效。

2.The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透析和腹膜透析两种。

3.To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察液透析滤过(HDF)对老年透析稳定性影响。

4.Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目：了解液透析和尿毒症对肿瘤志物水平影响。

5.Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造内瘘行液透析,针对其内瘘情况进行护理。

6.Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症如果利尿效果不佳或合并有力衰竭或高容量时,可以考虑液透析治疗。

7.Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目 提高对长期液透析获得性肾囊肿及肾细胞癌发病和临床特点认识。

8.Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目探讨影响出热病人急性肾衰少尿期预后因素及液透析在出热病人中应用时机。

9.Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目观察肾康注射液治疗慢性肾功能衰竭疗效,为控制慢性肾衰肾衰进程而延缓进行液透析提供一个好方法。